Cumberland Pharmaceuticals Inc.
 Booth Number:   2735

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. Cumberland markets Acetadote® (acetylcysteine) Injection for acetaminophen overdose. Acetadote administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.

2525 West End Avenue
Suite 950
Nashville, TN 37203
United States
www.cumberlandpharma.com